By Rick Aristotle Munarriz: Can I plead ignorance? One salty experience over a decade ago soured me on biotechnology stocks. I swore them off, but now I’m starting to regret blacklisting the promising space. I work with Charly Travers on the Motley Fool Rule Breakers newsletter service, and I’ve seen way too many of his biotech picks take off.
